Výsledky vyhledávání - "Sabrina Kelhef"

Data from Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

Autor: Paul Hofman, Thierry Jo Molina, Jérôme Mouroux, Jean-Philippe Jais, Nicolas Vénissac, Sabrina Kelhef, Stéphanie Sibon, Michel Poudenx, Eric Selva, Catherine Butori, Nadine Mourad, Eric Piaton, Sylvie Lantuejoul, Jean François Fléjou, Jean Michel Vignaud, Philippe Vielh, Marius I. Ilie, Christelle Bonnetaud, Véronique Hofman

Purpose: Pathologic TNM staging is currently the best prognostic factor for non‐small cell lung carcinoma (NSCLC). However, even in early-stage NSCLC, the recurrence rates after surgery range from 25% to 50%. The preoperative detection of circulati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5eab64145cf5892f938b229249d3011
https://doi.org/10.1158/1078-0432.c.6518299

Zobrazit plný text záznamu

Supplementary Data from Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

Supplementary Figures S1-S2; Supplementary Table S1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e8d9f4154da85f3b5eb1c8ac96fab55
https://doi.org/10.1158/1078-0432.22441159

Zobrazit plný text záznamu

Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker

Autor: Michel Poudenx, Sabrina Kelhef, Jean-Philippe Jais, Nicolas Venissac, Thierry Jo Molina, Nadine Mourad, Jérôme Mouroux, Philippe Vielh, Sylvie Lantuejoul, Véronique Hofman, Jean Michel Vignaud, Jean François Fléjou, Marius Ilie, Eric Selva, Christelle Bonnetaud, Catherine Butori, E. Piaton, Paul Hofman, Stéphanie Sibon

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research. 17(4)

Purpose: Pathologic TNM staging is currently the best prognostic factor for non-small cell lung carcinoma (NSCLC). However, even in early-stage NSCLC, the recurrence rates after surgery range from 25% to 50%. The preoperative detection of circulating

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39785ed0a2f58cc5b5a6e0ddf1af9c87
https://pubmed.ncbi.nlm.nih.gov/21098695

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání